Isolate Data
| Patient | Isolate | Region | Year | Species | Subtype | Source | Clone Method |
| 260Pt12 | 260Pt12BC | U.S. | 1995 | HIV1 | B | PBMC | None |
Treatment History
| Order | Regimen | Weeks |
| 1 | AZT | NA |
RT Sequence
| NRTIMajorDRMs | NRTIMinorDRMs | NNRTIMajorDRMs | NNRTIMinorDRMs | Polys | UnusualMuts |
| T215Y | S68G, D123E, P140X, K166R, D177E, I178IM, G196E, Q207N, R211K |
| >260Pt12BC| codons 30-245 KIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDGTKWRKLVDFRELNKRTQDFWE VQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDKEFRKYTAFTIPSINNETXGIRYQYNVL PQGWKGSPAIFQSSMTRILEPFRKQNPEMVIYQYMDDLYVGSDLEIEQHRTKIEELRNHL LKWGFYTPDKKHQKEPPFLWMGYELHPDKWTVQPIV |
References
| Author | Title | Citation |
| Demeter, LM | Delavirdine susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type I isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260). | AAC, 2000 |
| Gonzales, MJ | Extended spectrum of HIV-1 reverse transcriptase mutations in patients receiving multiple nucleoside analog inhibitors. | AIDS, 2003 |
| Rhee, SY | HIV-1 Protease and Reverse Transcriptase Mutations: Correlations with Antiretroviral Therapy in Subtype B Isolates and Implications for Drug-Resistance Surveillance. | J Infect Dis, 2005 |